We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the

  • jump to the main content
  • jump to the bottom of the page
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • News
  • Podcasts
  • Activities
  • Location and contact
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • Assistance and health
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Guide for patients and companions
    • Assistive Devices
  • Research
    • Home
    • About research
    • Research areas
    • Core Facilities
    • Work at Idibaps
  • Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • About the Clinic
Search
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • News
  • Podcasts
  • Activities
  • Location and contact
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
Navigation thread
  • Home
  • Organizational structure
  • Clinical Institute of Hematological and Oncological Diseases
  • Hematología Service
  • News
  • Hematología Service

Service News from Hematología

February 17 2022 2022-02-18

A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma

A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1

December 27 2021 2021-12-27

Vulnerable people caring for vulnerable people

Carers from the Formació i Treball APROP job pool provide home care for people in the early stages of a bone marrow transplant. Between 2020 and 2021

December 17 2021 2022-02-15

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

February 10 2021 2021-03-08

AEMPS authorises Hospital Clínic's CAR-T ARI-0001 for patients with acute lymphoblastic leukaemia

The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1

October 13 2020 2020-10-13

Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement

Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Ho1

July 2 2020 2020-07-13

Coronavirus has a more serious impact on patients with haematological diseases

People who have a haematological disease, such as lymphoma or leukaemia, present a state of immunosuppression caused both by the illness itself and t1

December 13 2019 2019-12-16

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1

October 9 2019 2019-10-10

Scientists discover cancer mutations in the unexplored area of genome

A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of1

July 29 2019 2019-08-02

Home treatment improves the quality of life in myeloma patients

Patients with multiple myeloma and mobility problems who receive treatment at home improve their quality of life by avoiding repeated visits to the h1

July 5 2019 2019-12-11

Evolution of cancer immunotherapy: from bone marrow transplant to CAR

The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining th1

navigation between pages below

Next page
  • page1 , current page.
  • page2
  • page3
Next page

Subscribe to the Newsletter of Clínic

Receive the latest news from our institution directly to your email.

Thanks for your subscription!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error has occurred and we have not been able to send your data, please try again later.
  • Assistance and health
    Assistance and health
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Guide for patients and companions
  • Research
    Research
    • Home
    • About research
    • Research areas
    • Core Facilities
  • Teaching
    Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • ES Contenido en español
  • CA Contingut en català
  • EN Current language Spanish
  • Cookies policy
  • Profile of the contracting party
  • Legal Notice
  • Data protection
  • Transparency portal
  • Privacy policy
© 2022